Stock Yards Bank & Trust Co. Has $2.94 Million Stake in The Clorox Company (NYSE:CLX)

Stock Yards Bank & Trust Co. trimmed its position in The Clorox Company (NYSE:CLX) by 5.7% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 21,510 shares of the company’s stock after selling 1,312 shares during the period. Stock Yards Bank & Trust Co.’s holdings in Clorox were worth $2,935,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in CLX. GoalVest Advisory LLC bought a new position in Clorox in the first quarter valued at about $31,000. First Foundation Advisors acquired a new position in Clorox during the 1st quarter valued at about $31,000. Core Wealth Advisors Inc. bought a new position in shares of Clorox in the 4th quarter valued at about $29,000. Innealta Capital LLC acquired a new stake in shares of Clorox during the 2nd quarter worth approximately $30,000. Finally, Trifecta Capital Advisors LLC raised its stake in shares of Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CLX has been the topic of a number of recent research reports. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Deutsche Bank Aktiengesellschaft raised their price target on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Argus raised Clorox to a “hold” rating in a research note on Tuesday, June 4th. Citigroup increased their target price on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Finally, TD Cowen assumed coverage on Clorox in a research report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 target price for the company. Six investment analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $143.50.

Clorox Trading Down 0.8 %

NYSE:CLX opened at $164.69 on Wednesday. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The stock has a market capitalization of $20.45 billion, a PE ratio of 85.33, a price-to-earnings-growth ratio of 3.29 and a beta of 0.40. The business’s 50-day simple moving average is $147.48 and its 200-day simple moving average is $143.42.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The business had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Sell-side analysts expect that The Clorox Company will post 6.63 earnings per share for the current fiscal year.

Clorox Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Wednesday, August 14th were paid a $1.22 dividend. This is a boost from Clorox’s previous quarterly dividend of $1.20. The ex-dividend date of this dividend was Tuesday, August 13th. This represents a $4.88 annualized dividend and a yield of 2.96%. Clorox’s payout ratio is presently 252.85%.

Insider Buying and Selling at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.51% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.